Transplantation of hypoxia preconditioned bone marrow mesenchymal stem cells enhances angiogenesis and neurogenesis after cerebral ischemia in rats

Neurobiology of Disease

Volumn 46, Issue 3, 2012, Pages 635-645

  Wei, Ling ^a,b   Fraser, Jamie L ^b   Lu, Zhong Yang ^b   Hu, Xinyang ^b   Yu, Shan Ping ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Angiogenesis; Bone marrow mesenchymal stem cell; Hypoxic preconditioning; Neurogenesis; Transplantation

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; CHEMOKINE RECEPTOR CXCR4; ERYTHROPOIETIN; GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR; GLUCOSE TRANSPORTER 1; HYPOXIA INDUCIBLE FACTOR 1ALPHA; NEURON SPECIFIC NUCLEAR PROTEIN; STROMAL CELL DERIVED FACTOR 1; VASCULOTROPIN; VASCULOTROPIN RECEPTOR;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BRAIN ISCHEMIA; CONTROLLED STUDY; DOWN REGULATION; ENDOTHELIUM CELL; HYPOXIC PRECONDITIONING; ISCHEMIC PRECONDITIONING; LOCOMOTION; MESENCHYMAL STEM CELL TRANSPLANTATION; MICROGLIA; MIDDLE CEREBRAL ARTERY OCCLUSION; NERVE CELL DIFFERENTIATION; NERVE REGENERATION; NERVOUS SYSTEM DEVELOPMENT; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; UPREGULATION;

ANIMALS; BLOTTING, WESTERN; BONE MARROW TRANSPLANTATION; BRAIN ISCHEMIA; CELL COUNT; CELL DIFFERENTIATION; CELLS, CULTURED; IMMUNOHISTOCHEMISTRY; INFLAMMATION; ISCHEMIC PRECONDITIONING; LIGATION; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; MIDDLE CEREBRAL ARTERY; NEOVASCULARIZATION, PHYSIOLOGIC; NEUROGENESIS; RATS; RATS, WISTAR; REAL-TIME POLYMERASE CHAIN REACTION; RECOVERY OF FUNCTION; STROKE;

EID: 84860834913     PISSN: 09699961     EISSN: 1095953X     Source Type: Journal    
DOI: 10.1016/j.nbd.2012.03.002     Document Type: Article

References (51)

1. Aggarwal R., et al. Genetic modification of ex-vivo expanded stem cells for clinical application. Front. Biosci. 2010, 15:854-871.
2. Angiolillo A.L., et al. Human interferon-inducible protein 10 is a potent inhibitor of angiogenesis in vivo. J. Exp. Med. 1995, 182:155-162.
3. Azarnoush K., et al. Enhancement of the functional benefits of skeletal myoblast transplantation by means of coadministration of hypoxia-inducible factor 1alpha. J. Thorac. Cardiovasc. Surg. 2005, 130:173-179.
4. Bystry R.S., et al. B cells and professional APCs recruit regulatory T cells via CCL4. Nat. Immunol. 2001, 2:1126-1132.
5. Caplan A.I., Dennis J.E. Mesenchymal stem cells as trophic mediators. J. Cell. Biochem. 2006, 98:1076-1084.
6. Ceradini D.J., et al. Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1. Nat. Med. 2004, 10:858-864.
7. Chen J., et al. Therapeutic benefit of intravenous administration of bone marrow stromal cells after cerebral ischemia in rats. Stroke 2001, 32:1005-1011.
8. Chen X., et al. Ischemic rat brain extracts induce human marrow stromal cell growth factor production. Neuropathology 2002, 22:275-279.
9. Chen Y., et al. Coaxing bone marrow stromal mesenchymal stem cells towards neuronal differentiation: progress and uncertainties. Cell. Mol. Life Sci. 2006, 63:1649-1657.
10. Danton G.H., Dietrich W.D. Inflammatory mechanisms after ischemia and stroke. J. Neuropathol. Exp. Neurol. 2003, 62:127-136.
11. Dominici M., et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 2006, 8:315-317.
12. Dufour J.H., et al. IFN-gamma-inducible protein 10 (IP-10; CXCL10)-deficient mice reveal a role for IP-10 in effector T cell generation and trafficking. J. Immunol. 2002, 168:3195-3204.
13. Francis K.R., Wei L. Human embryonic stem cell neural differentiation and enhanced cell survival promoted by hypoxic preconditioning. Cell Death Dis. 2010, 1:e22.
14. Gonzalez-Pal S., et al. Frontal lobe dysfunction in patients with epilepsy and chronic psychosis. Rev. Neurol. 1999, 28:219-223.
15. Hamano K., et al. Angiogenesis induced by the implantation of self-bone marrow cells: a new material for therapeutic angiogenesis. Cell Transplant. 2000, 9:439-443.
16. Hanisch U.K. Microglia as a source and target of cytokines. Glia 2002, 40:140-155.
17. Hess D.C., Borlongan C.V. Stem cells and neurological diseases. Cell Prolif. 2008, 41(Suppl. 1):94-114.
18. Hiasa K., et al. Gene transfer of stromal cell-derived factor-1alpha enhances ischemic vasculogenesis and angiogenesis via vascular endothelial growth factor/endothelial nitric oxide synthase-related pathway: next-generation chemokine therapy for therapeutic neovascularization. Circulation 2004, 109:2454-2461.
19. Hu X., et al. Hypoxic preconditioning enhances bone marrow mesenchymal stem cell migration via Kv2.1 channel and FAK activation. Am. J. Physiol. Cell Physiol. 2011, 301:C362-C372.
20. Hu X., et al. Transplantation of hypoxia-preconditioned mesenchymal stem cells improves infarcted heart function via enhanced survival of implanted cells and angiogenesis. J. Thorac. Cardiovasc. Surg. 2008, 135:799-808.
21. Keogh C.L., et al. The effect of recombinant human erythropoietin on neurovasculature repair after focal ischemic stroke in neonatal rats. J. Pharmacol. Exp. Ther. 2007, 322:521-528.
22. Krupinski J., et al. Role of angiogenesis in patients with cerebral ischemic stroke. Stroke 1994, 25:1794-1798.
23. Kurozumi K., et al. Mesenchymal stem cells that produce neurotrophic factors reduce ischemic damage in the rat middle cerebral artery occlusion model. Mol. Ther. 2005, 11:96-104.
24. Kurozumi K., et al. BDNF gene-modified mesenchymal stem cells promote functional recovery and reduce infarct size in the rat middle cerebral artery occlusion model. Mol. Ther. 2004, 9:189-197.
25. Le Blanc K., et al. Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study. Lancet 2008, 371:1579-1586.
26. Lennon D.P., et al. Cultivation of rat marrow-derived mesenchymal stem cells in reduced oxygen tension: effects on in vitro and in vivo osteochondrogenesis. J. Cell. Physiol. 2001, 187:345-355.
27. Li T.S., et al. Improved angiogenic potency by implantation of ex vivo hypoxia prestimulated bone marrow cells in rats. Am. J. Physiol. Heart Circ. Physiol. 2002, 283:H468-H473.
28. Li Y., Chopp M. Marrow stromal cell transplantation in stroke and traumatic brain injury. Neurosci. Lett. 2009, 456:120-123.
29. Li Y., et al. Allogeneic bone marrow stromal cells promote glial-axonal remodeling without immunologic sensitization after stroke in rats. Exp. Neurol. 2006, 198:313-325.
30. Liu X.B., et al. Therapeutic strategy of erythropoietin in neurological disorders. CNS Neurol. Disord. Drug Targets 2008, 7:227-234.
31. Malgieri A., et al. Bone marrow and umbilical cord blood human mesenchymal stem cells: state of the art. Int. J. Clin. Exp. Med. 2010, 3:248-269.
32. Momin E.N., et al. Mesenchymal stem cells: new approaches for the treatment of neurological diseases. Curr. Stem. Cell Res. Ther. 2010, 5:326-344.
33. Nandoe Tewarie R.D., et al. Bone marrow stromal cells for repair of the spinal cord: towards clinical application. Cell Transplant. 2006, 15:563-577.
34. Ogle M.E., et al. Primed for lethal battle: a step forward to enhance the efficacy and efficiency of stem cell transplantation therapy. J. Thorac. Cardiovasc. Surg. 2009, 138:527.
35. Ohmi K., et al. Activated microglia in cortex of mouse models of mucopolysaccharidoses I and IIIB. Proc. Natl. Acad. Sci. U. S. A. 2003, 100:1902-1907.
36. Ohtaki H., et al. Stem/progenitor cells from bone marrow decrease neuronal death in global ischemia by modulation of inflammatory/immune responses. Proc. Natl. Acad. Sci. U. S. A. 2008, 105:14638-14643.
37. Pacary E., et al. Synergistic effects of CoCl(2) and ROCK inhibition on mesenchymal stem cell differentiation into neuron-like cells. J. Cell Sci. 2006, 119:2667-2678.
38. Phinney D.G., Isakova I. Plasticity and therapeutic potential of mesenchymal stem cells in the nervous system. Curr. Pharm. Des. 2005, 11:1255-1265.
39. Rismanchi N., et al. Cell death and long-term maintenance of neuron-like state after differentiation of rat bone marrow stromal cells: a comparison of protocols. Brain Res. 2003, 991:46-55.
40. Sharp F.R., et al. Hypoxia-inducible factor in brain. Adv. Exp. Med. Biol. 2001, 502:273-291.
41. Shyu W.C., et al. Functional recovery of stroke rats induced by granulocyte colony-stimulating factor-stimulated stem cells. Circulation 2004, 110:1847-1854.
42. Singer N.G., Caplan A.I. Mesenchymal stem cells: mechanisms of inflammation. Annu. Rev. Pathol. 2011, 6:457-478.
43. Snider B.J., et al. Cycloheximide reduces infarct volume when administered up to 6h after mild focal ischemia in rats. Brain Res. 2001, 917:147-157.
44. Theus M.H., et al. In vitro hypoxic preconditioning of embryonic stem cells as a strategy of promoting cell survival and functional benefits after transplantation into the ischemic rat brain. Exp. Neurol. 2008, 210:656-670.
45. Tse W.T., et al. Suppression of allogeneic T-cell proliferation by human marrow stromal cells: implications in transplantation. Transplantation 2003, 75:389-397.
46. Wei L., et al. Transplantation of embryonic stem cells overexpressing Bcl-2 promotes functional recovery after transient cerebral ischemia. Neurobiol. Dis. 2005, 19:183-193.
47. Whitaker V.R., et al. Whisker stimulation enhances angiogenesis in the barrel cortex following focal ischemia in mice. J. Cereb. Blood Flow Metab. 2007, 27:57-68.
48. Wislet-Gendebien S., et al. Astrocytic and neuronal fate of mesenchymal stem cells expressing nestin. Brain Res. Bull. 2005, 68:95-102.
49. Woodbury D., et al. Adult rat and human bone marrow stromal cells differentiate into neurons. J. Neurosci. Res. 2000, 61:364-370.
50. Yamaguchi J., et al. Stromal cell-derived factor-1 effects on ex vivo expanded endothelial progenitor cell recruitment for ischemic neovascularization. Circulation 2003, 107:1322-1328.
51. Zacharek A., et al. Comparison of bone marrow stromal cells derived from stroke and normal rats for stroke treatment. Stroke 2010, 41:524-530.